![Mark D. Perrin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark D. Perrin
Plus aucun poste en cours
Profil
Mark D.
Perrin formerly worked at ConjuChem Biotechnologies, Inc., as President & Chief Executive Officer from 2005 to 2009, InVivo Therapeutics Corp., as Chairman & Chief Executive Officer, ConjuChem Biotechnologies, Inc., as President & Chief Executive Officer in 2005, Invivo Therapeutics Holdings Corp., as Chairman & Chief Executive Officer from 2014 to 2017, COR Therapeutics, Inc., as Executive Vice President-Commercial Operations from 1995 to 2001, Orphan Medical, Inc., as Chief Commercial Officer & Executive VP from 2002 to 2005, Lederle Laboratories, as Division Manager-Lederle Canada, Burroughs Wellcome, as Vice President-Marketing & Sales, and Dennan Consulting, as President.
Mr. Perrin received his undergraduate degree from Fordham University and Masters Business Admin degree from Kellogg School of Management.
Anciens postes connus de Mark D. Perrin
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. | Directeur Général | 18/12/2017 |
Dennan Consulting | President | 01/01/2014 |
ConjuChem Biotechnologies, Inc. /Old/
 ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | President | 31/08/2009 |
Orphan Medical, Inc.
 Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical and health care products | Corporate Officer/Principal | 01/01/2005 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Corporate Officer/Principal | 01/01/2001 |
Formation de Mark D. Perrin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
Orphan Medical, Inc.
Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical and health care products | Health Technology |
ConjuChem Biotechnologies, Inc. /Old/
ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Provides testing services | Commercial Services |
Burroughs Wellcome | |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
Invivo Therapeutics Holdings Corp.
 Invivo Therapeutics Holdings Corp. BiotechnologyHealth Technology Develops technologies for the treatment of spinal cord injuries | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dennan Consulting |
